Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Airò

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Trends in Molecular Medicine|November 28, 2012
Targeting CD4+CD28- T cells by blocking CD28 co-stimulationPaolo Airò, Mirko Scarsi
Clinical Rheumatology|May 29, 2004
Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinomaChiara M Antonioli, Paolo Airò
Journal of Scleroderma and Related Disorders|April 6, 2022
Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screenMaria-Grazia Lazzaroni, Paolo Airò
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Clinical and Experimental Rheumatology|February 19, 2024
The need for international multicentre collaborative studies to better characterise the clinical profile of anti-Th/To-positive patients: reply to the comment by Sakaida et alLiala Moschetti, Paolo Airò, Maria Grazia Lazzaroni
The Journal of Rheumatology|July 3, 2010
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosisAngela Ceribelli, Ilaria Cavazzana, Paolo Airò, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
Clinical Rheumatology|January 14, 2016
A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?Francesca Dall'Ara, Micol Frassi, Angela Tincani, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Trends in Molecular Medicine|November 28, 2012
Targeting CD4+CD28- T cells by blocking CD28 co-stimulationPaolo Airò, Mirko Scarsi
Clinical Rheumatology|May 29, 2004
Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinomaChiara M Antonioli, Paolo Airò
Journal of Scleroderma and Related Disorders|April 6, 2022
Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screenMaria-Grazia Lazzaroni, Paolo Airò
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Clinical and Experimental Rheumatology|February 19, 2024
The need for international multicentre collaborative studies to better characterise the clinical profile of anti-Th/To-positive patients: reply to the comment by Sakaida et alLiala Moschetti, Paolo Airò, Maria Grazia Lazzaroni
The Journal of Rheumatology|July 3, 2010
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosisAngela Ceribelli, Ilaria Cavazzana, Paolo Airò, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
Clinical Rheumatology|January 14, 2016
A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?Francesca Dall'Ara, Micol Frassi, Angela Tincani, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
Pageof 12